2MB2 Ventures

2MB2 Ventures is a private venture capital and strategic advisory firm focused on the biotechnology and life sciences sectors. The firm was established in 2021 by prominent industry veterans, including Mark Alles, the former Chairman and CEO of Celgene Corporation, and Dr. Mace Rothenberg, the former Chief Medical Officer of Pfizer. 2MB2 Ventures provides investment capital and high-level operational guidance to early- and mid-stage healthcare companies, particularly those developing innovative therapies in oncology and hematology. The firm leverages its leadership's extensive experience in global drug development, regulatory strategy, and commercialization to support its portfolio companies. Through its partners, 2MB2 Ventures is actively involved in the governance and strategic direction of several emerging biotech firms via board memberships and advisory roles.